Search Results "#PediatricEndocrinology"

Blogs

arrow_forward View More Results
X-Linked Hypophosphatemia XLH Treatment Market: How Is Burosumab Becoming the Fastest-Growing Targeted Therapy Replacing Conventional Management?
Posted by Surbhi on August 04 2026 at 04:14 PM   public
Burosumab for X-linked hypophosphatemia — the anti-FGF23 monoclonal antibody subcutaneous injection for phosphate-wasting rickets and osteomalacia representing the fastest-growing targeted therap...
Noonan Syndrome Market: How Are MEK Inhibitors and Next-Gen Growth Hormones Reshaping Treatment for This RASopathy?
Posted by Surbhi on June 29 2026 at 05:04 PM   public
MEK inhibitor breakthroughs in Noonan syndrome — the targeted MAPK pathway therapies demonstrating cardiac function improvement in children with severe hypertrophic cardiomyopathy, alongside Novo...
arrow_forward